PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists develop ‘pseudo cell’ formulation for vitreoretinal disease therapy

Scientists develop ‘pseudo cell’ formulation for vitreoretinal disease therapy
2023-10-23
(Press-News.org) Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and Beijing Chaoyang Hospital have developed a new "pseudo cell" formulation based on self-healing microcapsule-loading exosomes to treat diverse vitreoretinal diseases.

The study was published in Nature Biomedical Engineering on Oct. 23.

Vitreoretinal diseases include a wide spectrum of vision-threatening disorders, which may cause severe irreversible vision loss. The efficacy of current treatments for vitreoretinal diseases in clinic is generally unsatisfactory and treatments often cause several side effects. Moreover, frequently repeated treatments are often needed, leading to poor patient compliance.

In recent years, researchers have explored the possibility of cell-based therapy in ophthalmology. Despite some positive results, cell-based therapeutics in ophthalmology have encountered a series of problems, such as low cell-survival rates, instability of cell phenotype and the need for strict storage conditions, which have limited the clinical feasibility of these cell-based technologies.

The therapeutic benefits of many cell types are known to involve paracrine mechanisms. Therefore, researchers have explored the possibility of using more stable cell-secreting components (such as exosomes) as therapeutic components to treat ocular diseases. Inspired by this, researchers from IPE and Beijing Chaoyang Hospital have proposed a "pseudo cell" formulation platform.

In this platform, exosomes isolated from cells were loaded into self-healing microcapsules, called ExoCaps. "ExoCaps simulate functional cells in terms of size, internal structure, and secretion behavior," said Prof. MA Guanghui from IPE.

After intravitreal injection, ExoCaps settled in the inferior area of the vitreous cavity. Since blurred vision can be induced by suspension of living cells in the vitreous cavity, having the ExoCaps settle in the inferior area made it possible to avoid blurry vision. Moreover, exosomes were gradually released as the microcapsules degraded over a month, paving the way for a long-term therapeutic effect.

Using retinal ischemia-reperfusion injury (RIRI) and primed mycobacterial uveitis (PMU) models, the researchers detected therapeutic benefits from the application of two different ExoCap formulations, based on microencapsulation of mesenchymal stem cell-derived exosomes (MExo) and Treg cell-derived exosomes (TrExo), respectively. "Our ExoCap platform is flexible and can load exosomes of different cellular origins to meet varied therapeutic needs," said Prof. WEI Wei from IPE.

The potent therapeutic efficacies were verified in both murine and nonhuman primate models of vitreoretinal diseases. "This study is still at the preclinical stage. Given that exosomes are natural vesicles produced from endogenous cells with good biocompatibility and the microcapsule material [poly(lactic-co-glycolic acid)] has been approved for clinical use, ExoCap has the potential for translation to the clinic," said Prof. TAO Yong from Beijing Chaoyang Hospital.

END

[Attachments] See images for this press release:
Scientists develop ‘pseudo cell’ formulation for vitreoretinal disease therapy Scientists develop ‘pseudo cell’ formulation for vitreoretinal disease therapy 2

ELSE PRESS RELEASES FROM THIS DATE:

Increased West Antarctic Ice Sheet melting ‘unavoidable’

2023-10-23
Scientists ran simulations on the UK’s national supercomputer to investigate ocean-driven melting of the West Antarctic Ice Sheet: how much is unavoidable and must be adapted to, and how much melting the international community still has control over through reduction of greenhouse gas emissions. Taking into account climate variability like El Niño, they found no significant difference between mid-range emissions scenarios and the most ambitious targets of the 2015 Paris Agreement. Even under a best-case scenario of 1.5°C global temperature rise, melting will increase three times faster than ...

Novel cause of brain mosaicism and focal epilepsy identified

2023-10-23
(COLUMBUS, Ohio) – In most people, every cell in their body contains the same genetic information. However, sometimes people can have two or more genetically different sets of cells. This usually happens during fetal development and is known as mosaicism. Sometimes one of those groups of cells has genetic changes that can cause diseases or disorders. Neurologists, neurosurgeons and genomics experts have been working together to test for mosaicism in brain tissues resected during epilepsy surgery. Research has shown that mosaicism in the brain is a significant contributor to epilepsy. In a new study, recently published in Nature ...

Multitarget stool RNA test for colorectal cancer screening

2023-10-23
About The Study: In a clinical trial that included 8,920 participants, a noninvasive, multitarget stool RNA test (ColoSense) for colorectal cancer screening showed high sensitivity for colorectal neoplasia (colorectal cancer and advanced adenoma) with significant improvement in sensitivity relative to the fecal immunochemical test. Specificity for no lesions on colonoscopy was comparable to existing molecular diagnostic tests.  Authors: Erica K. Barnell, M.D., Ph.D., of the Washington University School of Medicine in St. Louis, is the corresponding author. To access ...

Plants transformed into detectors of dangerous chemicals

Plants transformed into detectors of dangerous chemicals
2023-10-23
What if your house plant could tell you your water isn’t safe? Scientists are closer to realizing this vision, having successfully engineered a plant to turn beet red in the presence of a banned, toxic pesticide.  To achieve this, UC Riverside researchers had to solve an engineering puzzle: how to enable a plant to sense and react to a chemical in the environment without damaging its ability to function normally in all other respects.  “The biggest piece here is we’ve created an environmental sensor without modifying ...

How long should kids isolate after they’ve contracted COVID-19?

2023-10-23
School policies that require students with COVID-19 to stay out of the classroom for five days are more than sufficient. That’s because children infected with the Omicron variant remained infectious for a median time of three days after testing positive for the virus, according to a study by the USC Schaeffer Center for Health Policy & Economics and Stanford University. “We're basically saying five days is more than sufficient; public-health and education leaders may consider shorter durations,” said co-author Neeraj ...

Homeless people are 16 times more likely to die suddenly

2023-10-23
A study led by UC San Francisco has found that people who are experiencing homelessness have a 16-fold higher rate of sudden death from heart attacks, as well as other causes.  The study focused on San Francisco County, which has one of the nation’s highest concentrations of homeless people. It found that the rate of sudden cardiac death was 7 times higher than the general population.   Some of these deaths may have been prevented with defibrillators and other public policy measures to improve health in this vulnerable population, according to the authors. The paper published ...

New study shows surprising effects of fire in North America’s boreal forests

2023-10-23
A new study, using a first-of-its-kind approach to analyze satellite imagery from boreal forests over the last three decades, found that fire may be changing the face of the region in a way researchers did not previously anticipate.  Historically, fires in North American boreal forests have led to coniferous trees being supplanted by deciduous trees, which are faster growing, take up more carbon and reflect more light, leading to cooling of the climate and decreased likelihood of fire.  The study, led by Northern Arizona University and published today in Nature Climate Change, found that, surprisingly, while forests do become more deciduous, ...

Chemists, engineers craft adjustable arrays of microscopic lenses

Chemists, engineers craft adjustable arrays of microscopic lenses
2023-10-23
They number in the thousands, light striking the phalanx of lenses arrayed on a face in geometric pattern, the beams refracting through transparent mounds no wider than a hair. A fly’s eye boasts roughly 4,000 microscopic lenses, a honeybee’s up to twice that many. These lenses, though, belong not to a compound eye but to polydimethylsiloxane — a flexible polymer long ranking as a favored playground of Nebraska’s Stephen Morin and his band of fellow chemists. With the aid of engineers Ruiguo Yang and Grayson Minnick, Morin’s team can now arrange and ...

Researchers develop DANGER analysis tool for the safer design of gene editing

Researchers develop DANGER analysis tool for the safer design of gene editing
2023-10-23
A team of researchers has developed a software tool called DANGER (Deleterious and ANticipatable Guides Evaluated by RNA-sequencing) analysis that provides a way for the safer design of genome editing in all organisms with a transcriptome. For about a decade, researchers have used the CRISPR technology for genome editing. However, there are some challenges in the use of CRISPR. The DANGER analysis overcomes these challenges and allows researchers to perform safer on- and off-target assessments without a reference genome. It holds the potential for applications in medicine, agriculture, and biological research. Their ...

Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery

Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery
2023-10-23
HOUSTON ― A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to results of a Phase III trial reported by researchers at The University of Texas MD Anderson Cancer Center.  The findings, published today in the New England Journal of Medicine, were first presented at the American Association for Cancer Research (AACR) Annual Meeting 2023.   The AEGEAN trial evaluated durvalumab given perioperatively, meaning therapy ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Scientists develop ‘pseudo cell’ formulation for vitreoretinal disease therapy